Gut epithelial surface and mucosal binding sites

The gut epithelial surface and mucosal binding sites represent a complex physiological interface consisting of the mucus layer, the carbohydrate-rich glycocalyx, and the apical membranes of enterocytes [Nature Reviews Gastroenterology & Hepatology, 2022]. This target is not a single molecular entity but rather a collection of receptors, glycoproteins (such as mucins), and glycolipids that facilitate nutrient absorption, provide a physical barrier against pathogens, and host the commensal microbiota [PubMed, 2021]. Biologically, these sites are responsible for selective nutrient absorption, physical protection against mechanical and chemical stress, and the mediation of innate immune responses [NIH, 2023]. In clinical practice, this surface is targeted by cytoprotective agents like sucralfate, which forms a physical barrier over ulcerated tissue, and non-absorbable antibiotics like rifaximin that exert local effects without systemic exposure [DrugBank]. Furthermore, the development of mucoadhesive drug delivery systems and oral vaccines relies on the specific interaction with these mucosal binding sites to enhance bioavailability and immunogenicity [Journal of Controlled Release, 2020]. Despite its therapeutic importance, the term is generally considered too broad for specific molecular target classification in drug discovery, as it encompasses a wide array of distinct biochemical interactions [StatPearls, 2023].

Other names

Intestinal mucosal barrierGut glycocalyxBrush border membraneIntestinal epithelial surfaceGastrointestinal mucosal binding sites

Mucoadhesion, physical barrier formation, competitive inhibition of pathogen binding, and local antimicrobial modulation.